ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RPRX Royalty Pharma PLC

27.41
1.03 (3.90%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 589.7M617.71M467.76M683.97M653.4M543.61M473.57M567.98M
Operating Income 432.27M233.2M28.33M513.58M363.27M153.52M468.93M-87.92M
Pre Tax Income 491.6M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M
Net Income 304.5M142.65M-456.08M340.76M227.63M72.11M494.34M4.78M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 456.87M238.37M-3.71M535.06M372.24M155.06M754.91M36.23M
EBITDA 432.27M233.2M28.33M513.58M363.27M153.52M468.93M-87.92M
Year End December 30 2023 20202020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 02.12B2.29B2.24B2.35B
Operating Income -13.79M1.64B1.41B913.92M1.5B
Pre Tax Income 51.28M1.7B1.24B230.06M1.7B
Net Income 51.28M975.04M619.73M42.83M1.13B
Preferred Dividends 00000
Basic Earnings Per Share (EPS) 0.140.7560.4640.0320.842
EBIT -13.79M1.87B1.38B858.91M1.82B
EBITDA -13.79M1.66B1.43B919.59M1.5B